Immunovia AB (FRA:1YR)

€ 0.0338 0.0013 (4%) Market Cap: 8.99 Mil Enterprise Value: 6.59 Mil PE Ratio: 0 PB Ratio: 2.83 GF Score: 42/100

Q2 2024 Immunovia AB (publ) Earnings Call Transcript
Aug 05, 2024

€0.105822 (-4.26%)

Earnings
Q3 2023 Immunovia AB (publ) Earnings Call Transcript
Nov 09, 2023

€0.156774 (+2.94%)

Earnings
Q2 2023 Immunovia AB (publ) Earnings Call Transcript
Aug 30, 2023

€0.0243 (-16.54%)

Earnings
Immunovia AB (publ) Corporate Call Transcript
Jul 12, 2023
Q1 2023 Immunovia AB (publ) Earnings Call Transcript
May 23, 2023

€0.105598 (-27.60%)

Earnings
Immunovia AB (publ) Special Call Transcript
May 03, 2023
Q4 2022 Immunovia AB (publ) Earnings Call Transcript
Feb 23, 2023

€0.372203 (-0.15%)

Earnings
Q3 2022 Immunovia AB (publ) Earnings Call Transcript
Nov 10, 2022

€1.55 (-1.39%)

Earnings
Q2 2022 Immunovia AB (publ) Earnings Call Transcript
Aug 24, 2022

€1.71 (-5.76%)

Earnings
Immunovia AB (publ)-Invitation to Immunovia's Presentation of PanFAM-1 Transcript
Jun 27, 2022
Q1 2022 Immunovia AB (publ) Earnings Call Transcript
Apr 28, 2022

€1.47 (-4.72%)

Earnings
Q4 2021 Immunovia AB (publ) Earnings Call Transcript
Feb 17, 2022

€1.86 (-20.11%)

Earnings
Q3 2021 Immunovia AB (publ) Earnings Call Transcript
Nov 11, 2021

€5.85 (-1.02%)

Earnings
Q2 2021 Immunovia AB (publ) Earnings Call Transcript
Aug 19, 2021

€6.03 (+5.64%)

Earnings
Immunovia AB (publ) KOL Event - Corporate Call Transcript
Jun 10, 2021
Q1 2021 Immunovia AB (publ) Earnings Call Transcript
Apr 28, 2021

€6.25 (-2.39%)

Earnings
Immunovia AB (publ) Corporate Call Transcript
Mar 30, 2021
Q4 2020 Immunovia AB (publ) Earnings Call Transcript
Feb 17, 2021

€6.55 (-3.38%)

Earnings
Immunovia AB (publ) - Special Call Transcript
Dec 17, 2020
Immunovia AB (publ) - Special Call Transcript
Dec 03, 2020
Nine Months 2020 Immunovia AB (publ) Earnings Call Transcript
Nov 12, 2020

Earnings
Immunovia AB (publ) - Special Call Transcript
Nov 03, 2020
Immunovia AB (publ) Announces Completion of Analysis from the IMMray™ PanCan-d Verification Study - Conference Call Transcript
Oct 26, 2020
Immunovia AB (publ) CEO Transition - Conference Call Transcript
Aug 26, 2020
Half Year 2020 Immunovia AB (publ) Earnings Call Transcript
Aug 20, 2020

Earnings
Immunovia AB (publ) Corporate Analyst Meeting Transcript
Jun 30, 2020
Immunovia AB (publ) to Discuss COVID-19 and IMMray™ PanCan-d Launch Preparations Conference Call Transcript
May 27, 2020
Immunovia AB (publ) - Special Call Transcript
May 13, 2020
Q1 2020 Immunovia AB (publ) Earnings Call Transcript
Apr 28, 2020

Earnings
Immunovia AB (publ) - Special Call Transcript
Apr 01, 2020
Q4 2019 Immunovia AB (publ) Earnings Call Transcript
Feb 14, 2020

Earnings
Nine Months 2019 Immunovia AB (publ) Earnings Call Transcript
Nov 08, 2019

Earnings
Immunovia AB (publ) - Special Call Transcript
Sep 09, 2019
Q2 2019 Immunovia AB (publ) Earnings Call Transcript
Aug 23, 2019

Earnings
Immunovia AB (publ) - Special Call Transcript
Jun 03, 2019
Q1 2019 Immunovia AB (publ) Earnings Call Transcript
Apr 29, 2019

Earnings
Immunovia AB (publ) - Special Call Transcript
Mar 04, 2019
Full Year 2018 Immunovia AB (publ) Earnings Call Transcript
Feb 14, 2019

Earnings

Q2 2022 Immunovia AB (publ) Earnings Call Transcript

Aug 24, 2022 / 11:00AM GMT

Release Date Price: €1.71 (-5.76%)

Transcript

Operator

Ladies and gentlemen, welcome to the Immunovia Q2 Interim Report 2022 Conference Call. I'm Moira, the Chorus Call operator. (Operator Instructions) And the conference is being recorded. (Operator Instructions)

At this time, it's my pleasure to hand over to Karin Almqvist Liwendahl, CFO. Please go ahead.

Karin Almqvist Liwendahl;publ;CFO

Immunovia AB

()-

Thank you so much, and welcome to you all joining us here today for the presentation of Immunovia's second quarter results. Present here in Lund is Philipp Mathieu, our CEO; and myself, Karin Almqvist, and I'm the CFO. Joining from the U.S. is Jeff Borcherding, our CEO of our U.S. operations.

Before we start the presentation, some practical aspects. There will be a Q&A session afterwards, and our operator will guide you on how to ask the questions. (Operator Instructions) We aim to close the call at 2 p.m. the latest, whereafter you will find it uploaded on our website.

With that, I'd like to hand over to our CEO for the presentation. Philipp,

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.